FLOW

Switzerland, CH · 1 known investors

Flow provides a consumer-facing neurostimulation device using transcranial direct current stimulation (tDCS) for depression treatment. The technology is clinically validated and available for at-home use to balance activity in mood-regulating brain regions.

Digital HealthHealthtechMedical Devices